🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludara...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2004-01
Trial ID
NCT00079144
The purpose of this study is to test the side effects of an investigational...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-08-13
Trial ID
NCT01176474
The purpose of this study is to determine whether vaccination with melanoma...
Status
Completed
Location
Oncology Department, Lausanne University Hospital (CHUV) and University of Lausanne
Start Date
2004-02
Trial ID
NCT00112242
The purpose of this study is to determine the biological recommended dose o...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2009-11
Trial ID
NCT01003808
Treatments Being Tested
This phase II trial studies the effect of a vaccine called CDX-1401 given w...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2014-04-09
Trial ID
NCT02129075
Treatments Being Tested
PDC-LUNG-101 trial is an open-label, dose-escalation, phase I/II study to a...
Status
Active Not Recruiting
Location
Grand Hôpital de Charleroi
Start Date
2019-09-10
Trial ID
NCT03970746
Treatments Being Tested